Clinical Trial Update: A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety, tolerability, and efficacy of V158866 for central neuropathic pain following spinal cord injury; results were posted in 2017…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• V158866

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Neuropathic Pain Due to Spinal Cord Injury | Phase 2 | Status: COMPLETED | Results posted: 2017-04-11